Compare LC & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | LC | HTFL |
|---|---|---|
| Founded | 2006 | 2007 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.4B |
| IPO Year | N/A | N/A |
| Metric | LC | HTFL |
|---|---|---|
| Price | $15.96 | $23.41 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $22.67 | ★ $39.20 |
| AVG Volume (30 Days) | ★ 2.7M | 1.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $40.42 |
| Revenue Next Year | $15.91 | $22.73 |
| P/E Ratio | $13.66 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.90 | $20.13 |
| 52 Week High | $21.67 | $41.22 |
| Indicator | LC | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 39.00 | 38.08 |
| Support Level | $15.00 | $20.13 |
| Resistance Level | $17.63 | $29.86 |
| Average True Range (ATR) | 1.00 | 2.42 |
| MACD | -0.16 | -0.74 |
| Stochastic Oscillator | 28.16 | 31.88 |
LendingClub Corp is a company engaged in operating an online lending marketplace platform that connects borrowers and investors for the provision of the loan facility. It offers investors access to an asset class that has generally been closed to many investors and only available on a limited basis to institutional investors. The company through the platform offers loan products such as personal, education and patient finance, small business, and auto to interested investors. It generates a majority of the revenue from the transaction fees received from the platform's role in accepting and decisioning applications on behalf of the bank partners to enable loan originations.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.